Compare
Gilead Sciences vs United Therapeutics (GILD vs UTHR)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Gilead Sciences (GILD) returned +36.1% and United Therapeutics (UTHR) +25.6%; so far this year the figures are +36.0% and +15.3%.
Gilead Sciences is the larger company by market value, about 8.6 times the size of United Therapeutics.
Revenue grew +6.5% at GILD and +1.9% at UTHR over the last year.
GILD yields 1.95%. UTHR pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| GILD | UTHR | |
|---|---|---|
| Price | $166.89 | $562.02 |
| 1-day | -0.41% | -0.65% |
| YTD | +35.97% | +15.35% |
| 1 year | +36.15% | +25.61% |
| 3 years | +108.12% | +150.81% |
| Market cap | $207.0B | $23.9B |
| P/E | — | 21.2 |
| P/S | 6.68 | 7.51 |
| P/B | 15.87 | 3.81 |
| Revenue growth | +6.50% | +1.90% |
| EPS growth | -149.00% | +0.30% |
| Gross margin % | 79.9 | 86.3 |
| Net margin % | -12.5 | 38.6 |
| ROE % | -29.6 | 19.6 |
| Debt / equity | 2.01 | 0.00 |
| FCF yield % | 6.7 | 3.6 |
| Dividend yield % | 1.95 | — |
| Beta | 0.37 | 0.37 |
| RSI (14) | 60.2 | 48.9 |
| Technical rating |